Trial Profile
Therapeutic effects of direct renin inhibitor aliskiren on ambulatory blood pressure profile in essential hypertensives
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 10 May 2012
Price :
$35
*
At a glance
- Drugs Aliskiren (Primary)
- Indications Essential hypertension
- Focus Pharmacodynamics
- 10 May 2012 New trial record